A Health Podyssey

Health Affairs
undefined
Oct 1, 2024 • 27min

Jay Bhatt on the Social Drivers of Health

Health Affairs' Editor-in-Chief Alan Weil interviews Dr. Jay Bhatt, Managing Director of the Deloitte Center for Health Solutions and the Deloitte Health Equity Institute, to highlight the upcoming season of Research & Justice For All that focuses on social drivers of health and the role that Deloitte has played in pursuing health equity goals across the life sciences and health care industry. Before the second season of Research & Justice For All arrives, check out the last season focused on Private Sector Solutions.Order the September 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Sep 24, 2024 • 21min

Melissa Aldridge on Private Equity Acquisitions Of Hospices

Health Affairs' Editor-in-Chief Alan Weil interviews Melissa Aldridge of Icahn School of Medicine at Mount Sinai and James J. Peters Bronx Veterans Affairs Medical Center about her recent paper exploring the increasing trend of private equity acquisitions of hospices and how ownership structures still remain complex and opaque.Order the September 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Sep 17, 2024 • 23min

Andrew Feher on The Effects Of Email For Insurance Engagement Efforts

Health Affairs' Editor-in-Chief Alan Weil interviews Andrew Feher of Department of Health Care Access and Information about his recent paper exploring how the incorporation of email reminders saw increases in eligibility verification and continued subsidy receipt for enrollees in California's Affordable Care Act marketplace.Order the September 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Sep 10, 2024 • 28min

Benedic Ippolito on the Once and Future Costs of Anti-Obesity Drugs

Health Affairs' Editor-in-Chief Alan Weil interviews Benedic Ippolito of American Enterprise Institute about his recent paper exploring how expanding Medicare coverage of anti-obesity medicines could result in increased annual spending.Order the September 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Sep 3, 2024 • 20min

Jiani Yu on the Current Telehealth Landscape & Opportunities

Health Affairs' Editor-in-Chief Alan Weil interviews Jiani Yu of Cornell University about her recent paper that explores how telehealth use and delivery differs significantly by physician and practice characteristics.Order the September 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Aug 27, 2024 • 23min

Dongzhe Hong on Biosimilar Uptake in the US

Health Affairs' Editor-in-Chief Alan Weil interviews Dongzhe Hong of Brigham and Women’s Hospital and Harvard University on his recent paper that explores how patient and prescriber factors play into biosimilar uptake in the US.Order the August 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Aug 20, 2024 • 20min

Kamyar Nasseh on the Growing Role of Private Equity in Dentistry

Health Affairs' Editor-in-Chief Alan Weil interviews Kamyar Nasseh of the American Dental Association on his recent study that identifies the growing role of private equity in dental practices.Order the August 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Aug 13, 2024 • 24min

Sanjay Basu on How Cost-Effectiveness Analyses Can Perpetuate Health Disparities

Health Affairs' Editor-in-Chief Alan Weil interviews Sanjay Basu of Waymark on his recent study that considers a potential risk of perpetuating health disparities with the continued utilization of cost-effectiveness analyses to inform health care and public health policy decisions.Order the August 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Aug 6, 2024 • 23min

Brandy Lipton on the Medicaid Coverage Gaps of Eye Care

Health Affairs' Editor-in-Chief Alan Weil interviews Brandy Lipton of the University of California, Irvine on her recent paper exploring how most state Medicaid programs offer coverage for routine eye exams for adults, but noticeable coverage discrepancies of other routine vision care services remain.Order the August 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
undefined
Jul 30, 2024 • 22min

Jennifer Kao on How an FDA Program Reduced Clinical Development Times for Some Drugs

Health Affairs' Editor-in-Chief Alan Weil interviews Jennifer Kao of the University of California Los Angeles on her recent paper that explores the impact of the Food and Drug Administration's breakthrough therapy designation program on the reduction of late-stage drug development time.Order the July 2024 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app